ECM
MDGL icon

Element Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Element Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-55,365
Closed -$5.04M – 32
2019
Q4 		$5.04M Buy
+55,365
New +$5.37M 1.08% 22
2018
Q4 		– Sell
-1,616
Closed -$346K – 792
2018
Q3 		$346K Buy
1,616
+880
+120% +$221K 0.01% 534
2018
Q2 		$206K Buy
+736
New +$129K 0.01% 706

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Element Capital Management's MDGL Position: Q1 2020 in Review

Element Capital Management sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2020, closing a stake of 55,365 shares — an estimated $5.04M sold.

Element Capital Management first reported a position in MDGL in Q2 2018 and held it in 3 quarters. The position peaked at $5.04M in Q4 2019. 109 funds tracked by Wall St. Rank hold MDGL as of Q1 2020.

  • Element Capital Management reported no remaining Madrigal Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Element Capital Management sold 55,365 Madrigal Pharmaceuticals shares in Q1 2020, an estimated $5.04M.
  • Element Capital Management first reported a position in Madrigal Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Element Capital Management's Madrigal Pharmaceuticals position peaked at $5.04M in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2020.

Based on Element Capital Management's 13F filing for Q1 2020, filed 12 May 2020.